127 related articles for article (PubMed ID: 12484569)
1. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia.
Kaneko K; Yoshida K; Arima K; Ohara S; Miyajima H; Kato T; Ohta M; Ikeda SI
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1069-77. PubMed ID: 12484569
[TBL] [Abstract][Full Text] [Related]
2. Aceruloplasminemia, an iron metabolic disorder.
Miyajima H
Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552
[TBL] [Abstract][Full Text] [Related]
3. Aceruloplasminemia.
Miyajima H
Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
[TBL] [Abstract][Full Text] [Related]
4. Molecular and pathological basis of aceruloplasminemia.
Kono S; Miyajima H
Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161
[TBL] [Abstract][Full Text] [Related]
5. Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia.
Oide T; Yoshida K; Kaneko K; Ohta M; Arima K
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):170-6. PubMed ID: 16599945
[TBL] [Abstract][Full Text] [Related]
6. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain.
Kaneko K; Nakamura A; Yoshida K; Kametani F; Higuchi K; Ikeda S
Free Radic Res; 2002 Mar; 36(3):303-6. PubMed ID: 12071349
[TBL] [Abstract][Full Text] [Related]
7. [Neuronal cell damage in aceruloplasminemia].
Miyajima H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
[TBL] [Abstract][Full Text] [Related]
8. Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness.
Kaneko K; Hineno A; Yoshida K; Ohara S; Morita H; Ikeda S
Hum Pathol; 2012 Mar; 43(3):451-6. PubMed ID: 21889188
[TBL] [Abstract][Full Text] [Related]
9. Increased lipid peroxidation in the brains of aceruloplasminemia patients.
Yoshida K; Kaneko K; Miyajima H; Tokuda T; Nakamura A; Kato M; Ikeda S
J Neurol Sci; 2000 Apr; 175(2):91-5. PubMed ID: 10831768
[TBL] [Abstract][Full Text] [Related]
10. Microglia and astroglia prevent oxidative stress-induced neuronal cell death: implications for aceruloplasminemia.
Oshiro S; Kawamura K; Zhang C; Sone T; Morioka MS; Kobayashi S; Nakajima K
Biochim Biophys Acta; 2008 Feb; 1782(2):109-17. PubMed ID: 18187051
[TBL] [Abstract][Full Text] [Related]
11. Aceruloplasminemia.
Kono S
Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
[TBL] [Abstract][Full Text] [Related]
12. Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice.
Kaneko K; Hineno A; Yoshida K; Ikeda S
Neurosci Lett; 2008 Nov; 446(1):56-8. PubMed ID: 18804145
[TBL] [Abstract][Full Text] [Related]
13. Redox active iron accumulation in aceruloplasminemia.
Gonzalez-Cuyar LF; Perry G; Miyajima H; Atwood CS; Riveros-Angel M; Lyons PF; Siedlak SL; Smith MA; Castellani RJ
Neuropathology; 2008 Oct; 28(5):466-71. PubMed ID: 18282164
[TBL] [Abstract][Full Text] [Related]
14. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
[TBL] [Abstract][Full Text] [Related]
15. [Pathological study on central nervous system of patients with hereditary ceruloplasmin deficiency].
Kawanami T
Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1585-90. PubMed ID: 15384687
[No Abstract] [Full Text] [Related]
16. Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains.
Miyajima H; Kono S; Takahashi Y; Sugimoto M
Blood Cells Mol Dis; 2002; 29(3):433-8. PubMed ID: 12547232
[TBL] [Abstract][Full Text] [Related]
17. Aceruloplasminemia: an update.
Kono S
Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
[TBL] [Abstract][Full Text] [Related]
18. Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage.
Martínez A; Carmona M; Portero-Otin M; Naudí A; Pamplona R; Ferrer I
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1122-36. PubMed ID: 19018247
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of Copper in the Iron-Rich Particles of Aceruloplasminemia Brain.
Yoshida K; Hayashi H; Wakusawa S; Shigemasa R; Koide R; Ishikawa T; Tatsumi Y; Kato K; Ohara S; Ikeda SI
Biol Trace Elem Res; 2017 Jan; 175(1):79-86. PubMed ID: 27272717
[TBL] [Abstract][Full Text] [Related]
20. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia.
Klomp LW; Gitlin JD
Hum Mol Genet; 1996 Dec; 5(12):1989-96. PubMed ID: 8968753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
